SCHEMBL24296648

SCHEMBL24296648

Cc1cc(S(=O)(=O)N2CCCC2)ccn1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.55
▸ PKM P14618 3/20 0.53
▸ USP2 O75604 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ MCOLN3 Q8TDD5 3/20 0.49
▸ CRHBP P24387 1/20 0.49
▸ CRHR2 Q13324 1/20 0.49
▸ POLB P06746 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ GAA P10253 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ TSHR P16473 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19457373 0.83 HSD11B1 (0.48) ALDH1A1SMN1; SMN2MEN1KMT2AMCOLN3
SCHEMBL22601463 0.80 LMNA (0.56) ALDH1A1USP2SMN1; SMN2MEN1KMT2A
SCHEMBL21986228 0.75 POLB (0.64) ALDH1A1PKMUSP2SMN1; SMN2MEN1
SCHEMBL3466579 0.74 UHRF1 (0.46) ALDH1A1SMN1; SMN2KDM4EHTTGAA
SCHEMBL15010831 0.72 ALDH1A1 (0.73) ALDH1A1PKMUSP2MEN1KMT2A
SCHEMBL12320892 0.72 ALDH1A1 (0.69) ALDH1A1PKMUSP2SMN1; SMN2MEN1
SCHEMBL13801171 0.72 UHRF1 (0.48) SMN1; SMN2
SCHEMBL12320941 0.71 ALDH1A1 (0.67) ALDH1A1USP2SMN1; SMN2MEN1KMT2A
SCHEMBL27470371 0.71 KDM4E (0.54) ALDH1A1USP2SMN1; SMN2MEN1KMT2A
SCHEMBL14317797 0.71 CA1 (0.46) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047288-A9 METHODS OF TREATING CANCER INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (US) 2022-03-31 — — WO disclosed
Send feedback